DiaMedica Therapeutics Inc.

DMAC

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001401040

SEC filings (opens in a new tab)

No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.

Superinvestors holding DMAC, Q2 2026

See all superinvestors

No superinvestor reported holding DMAC in Q2 2026.